feed,title,long_url,short_url
Benzinga,Terns Shares Drop After Mixed Results From Mid-Stage NASH Trial With FXR Agonist,https://benzinga.com/general/biotech/21/06/21550317/terns-shares-drop-after-mixed-results-from-mid-stage-nash-trial-with-fxr-agonist,https://j.mp/3wp7S28
